Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Muscarinic antagonists with PARP and SIR modulating activity as agents for inflammatory diseases

Muscarinic antagonists with PARP and SIR modulating activity as agents for inflammatory diseases

US Patent 8039464 · Granted Oct 18, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of effecting neuroprotection using soluble neuregulin isoforms2025
Method of effecting neuroprotection using soluble neuregulin isoforms2020
Method of effecting neuroprotection using soluble Neuregulin isoforms2019
Use of neuregulin-β as an indicator and/or target2013
Muscarinic antagonists with parp and sir modulating activity as cytoprotective a2013
Annexin A3 for cancer diagnosis2013
Autoimmune regulation of prostate cancer by annexin A32013
Monoclonal anti-annexin A3 antibodies for the detection of prostate carcinoma2011
Use of finasteride, dutasteride and related compounds for the prevention or trea2011
Neuregulin-β isoform2011
Neuregulin-β isoforms associated with neuronal processes2010
Use of substances for treating tumors2010